journal article·2024-06-19

Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy

Yinghao Ding, Shengyi Zhang, Wei Li, Xiaodong Chen, Jun Li, Xiangyang Zhang, Zhenghao Zhang, Yuanbo Hu, Zhimou Yang, Zhi-Wen Hu, Xian Shen

Nano Letters· Volume 24· Issue 24
Publisher page

Abstract

T lymphocytes (CTLs) are highly promising for cancer treatment. The specific interaction between T-cell receptors and peptide-MHC-I complexes (pMHC-I) on cancer cell membranes critically determines their therapeutic outcomes. However, the lack of appropriate endogenous antigens for MHC-I presentation disables tumor recognition by CTLs. By devising three antigen-loaded self-assembling peptides of pY-K(Ag)-ERGD, pY-K(Ag)-E, and Y-K(Ag)-ERGD to noncovalently generate light-activatable supramolecular antigens at tumor sites in different manners, we report pY-K(Ag)-ERGD as a promising candidate to endow tumor cells with pMHC-I targets on demand. Specifically, pY-K(Ag)-ERGD first generates low-antigenic supramolecular antigens on cancer cell membranes, and a successive light pulse allows antigen payloads to efficiently release from the supramolecular scaffold, directly producing antigenic pMHC-I. Intravenous administration of pY-K(Ag)-ERGD enables light-controlled tumor inhibition when combined with adoptively transferred antigen-specific CTLs. Our strategy is feasible for broadening tumor antigen repertoires for T-cell immunotherapies and advancing precision-controlled T-cell immunotherapies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · Immune Cell Function and Interaction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, P. R. China

Key Laboratory of Bioactive Materials, Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, P. R. China

Funding

Zhejiang Provincial Ten Thousand Plan for Young Top Talents · Key Research and Development Program of Zhejiang Province · National Natural Science Foundation of China · Wenzhou City

References (76)

Show source-provided references
1. 10.1038/s41423-020-0488-610.1038/s41423-020-0488-6 ↗
2. 10.1016/j.immuni.2023.09.00510.1016/j.immuni.2023.09.005 ↗
3. 10.1016/j.it.2023.07.00510.1016/j.it.2023.07.005 ↗
4. 10.1126/science.132387810.1126/science.1323878 ↗
5. 10.1038/nature0384310.1038/nature03843 ↗
6. 10.1126/science.aaa496710.1126/science.aaa4967 ↗
7. 10.1038/s41392-023-01674-310.1038/s41392-023-01674-3 ↗
8. 10.1038/s41587-022-01567-w10.1038/s41587-022-01567-w ↗
9. 10.1126/science.abd132910.1126/science.abd1329 ↗
10. 10.1038/s41571-018-0142-810.1038/s41571-018-0142-8 ↗
11. 10.1038/s41568-021-00339-z10.1038/s41568-021-00339-z ↗
12. 10.1038/s43018-021-00247-z10.1038/s43018-021-00247-z ↗
13. 10.1038/s43018-023-00588-x10.1038/s43018-023-00588-x ↗
14. 10.1038/s41577-022-00707-210.1038/s41577-022-00707-2 ↗
15. 10.1158/2159-8290.CD-20-081210.1158/2159-8290.CD-20-0812 ↗
16. 10.1038/s41565-021-00972-710.1038/s41565-021-00972-7 ↗
17. 10.1038/s41551-021-00805-x10.1038/s41551-021-00805-x ↗
18. 10.1186/s12943-023-01899-410.1186/s12943-023-01899-4 ↗
19. 10.1038/s41467-019-08534-110.1038/s41467-019-08534-1 ↗
20. 10.1038/s41467-020-14821-z10.1038/s41467-020-14821-z ↗
21. 10.1038/s41587-019-0404-810.1038/s41587-019-0404-8 ↗
22. 10.1186/s12943-022-01574-010.1186/s12943-022-01574-0 ↗
23. 10.1158/0008-5472.CAN-21-220010.1158/0008-5472.CAN-21-2200 ↗
24. 10.1016/j.scib.2024.01.03910.1016/j.scib.2024.01.039 ↗
25. 10.1038/s41392-022-01270-x10.1038/s41392-022-01270-x ↗
26. 10.1039/C7CS90102J10.1039/C7CS90102J ↗
27. 10.1038/s41570-020-0215-y10.1038/s41570-020-0215-y ↗
28. 10.1038/s41570-022-00373-x10.1038/s41570-022-00373-x ↗
29. 10.1038/s41573-022-00505-410.1038/s41573-022-00505-4 ↗
30. 10.1021/acs.accounts.2c0013510.1021/acs.accounts.2c00135 ↗
31. 10.1021/acs.accounts.3c0054210.1021/acs.accounts.3c00542 ↗
32. 10.1039/D2CS00759B10.1039/D2CS00759B ↗
33. 10.1039/D2CS00999D10.1039/D2CS00999D ↗
34. 10.1021/jacs.9b0473010.1021/jacs.9b04730 ↗
35. 10.1126/sciadv.aaz898510.1126/sciadv.aaz8985 ↗
36. 10.1126/sciadv.abm783310.1126/sciadv.abm7833 ↗
37. 10.1038/s41565-020-0739-910.1038/s41565-020-0739-9 ↗
38. 10.1002/adma.20210059510.1002/adma.202100595 ↗
39. 10.1002/adma.20220013910.1002/adma.202200139 ↗
40. 10.1016/j.matt.2019.09.01510.1016/j.matt.2019.09.015 ↗
41. 10.1021/acs.chemrev.0c0030610.1021/acs.chemrev.0c00306 ↗
42. 10.1021/acs.nanolett.8b0348210.1021/acs.nanolett.8b03482 ↗
43. 10.1021/jacs.6b1104110.1021/jacs.6b11041 ↗
44. 10.1038/s41565-023-01401-710.1038/s41565-023-01401-7 ↗
45. 10.1021/jacs.9b0334610.1021/jacs.9b03346 ↗
46. 10.1021/acs.nanolett.8b0440610.1021/acs.nanolett.8b04406 ↗
47. 10.1021/acs.nanolett.3c0236210.1021/acs.nanolett.3c02362 ↗
48. 10.1016/j.nantod.2023.10197410.1016/j.nantod.2023.101974 ↗
49. 10.1021/jacs.1c0792310.1021/jacs.1c07923 ↗
50. 10.1002/adma.20227000510.1002/adma.202270005 ↗
51. 10.1002/adfm.20220696910.1002/adfm.202206969 ↗
52. 10.1002/smtd.20220141610.1002/smtd.202201416 ↗
53. 10.1002/anie.20211183910.1002/anie.202111839 ↗
54. 10.1016/j.biomaterials.2013.10.07210.1016/j.biomaterials.2013.10.072 ↗
55. 10.1038/nprot.2006.12110.1038/nprot.2006.121 ↗
56. 10.1039/D2SC01672A10.1039/D2SC01672A ↗
57. 10.1038/s41578-023-00589-310.1038/s41578-023-00589-3 ↗
58. 10.1073/pnas.120158610910.1073/pnas.1201586109 ↗
59. 10.1073/pnas.141654311210.1073/pnas.1416543112 ↗
60. 10.1016/0092-8674(90)90020-F10.1016/0092-8674(90)90020-F ↗
61. 10.1038/nbt.404710.1038/nbt.4047 ↗
62. 10.1038/s12276-019-0329-910.1038/s12276-019-0329-9 ↗
63. 10.1021/jacs.2c1182310.1021/jacs.2c11823 ↗
64. 10.7150/thno.3920310.7150/thno.39203 ↗
65. 10.1016/j.molcel.2018.12.01810.1016/j.molcel.2018.12.018 ↗
66. 10.1073/pnas.24260009910.1073/pnas.242600099 ↗
67. 10.1038/nm86910.1038/nm869 ↗
68. 10.1038/s41598-021-99347-010.1038/s41598-021-99347-0 ↗
69. Gao F. G. · Cancer Res. · 2002 · 62 · 6438
70. 10.1038/s41467-017-01296-810.1038/s41467-017-01296-8 ↗
71. 10.1002/adma.20197032110.1002/adma.201970321 ↗
72. 10.1146/annurev-immunol-032712-09591010.1146/annurev-immunol-032712-095910 ↗
73. 10.1016/j.it.2024.01.00910.1016/j.it.2024.01.009 ↗
74. 10.1073/pnas.181523911610.1073/pnas.1815239116 ↗
75. 10.1038/s41586-021-03368-810.1038/s41586-021-03368-8 ↗
76. 10.1038/s41587-022-01464-210.1038/s41587-022-01464-2 ↗